ArticleFrontiers in molecular biosciences2026
Molecular dynamics analysis of a docking-derived baicalein-PPARγ ligand-binding-domain model suggests a pocket-associated AF-2-anchor-silent ensemble.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Baicalein was examined in a selected docking-derived peroxisome proliferator-activated receptor γ (PPARγ) ligand-binding-domain (LBD) model to test whether pocket association, local helix 12 (H12) organization, and canonical activation function-2 (AF-2) anchoring were coupled under the sampled simulation conditions. Because no baicalein-bound PPARγ cocrystal structure was used, the results are interpreted as a selected-pose molecular dynamics model rather than as a definitive experimental binding mode. Three independent 100-ns replicas were analyzed with bound-state filtering, H12 and AF-2 descriptors, arm-resolved energetic decomposition, interaction fingerprints, a local Tyr473-engagement potential of mean force (PMF), and exploratory state annotation. Baicalein remained spatially associated with the ligand-binding pocket by the minimum-distance and center-of-mass criteria, whereas pocket-shell contact persistence was replica-dependent, with retained fractions of 94.20%, 94.00%, and 71.64% in replicas 1-3. Within bound-state-filtered frames and under the selected neutral baicalein/HIE histidine model, direct ligand hydrogen bonds to Ser289, His323, His449, and Tyr473 were not detected, and the AF-2 anchor-panel union occupancy was 0.00%. This anchor-negative pattern occurred despite measurable local H12 order, indicating that local H12 structural persistence and canonical AF-2 anchor assembly were separable in the selected model. Arm-resolved molecular mechanics/generalized Born surface area (MM/GBSA) descriptors and ProLIF fingerprints supported mixed Arm II/Arm III participation, with recurrent van der Waals contacts involving Cys285, Ile341, Leu330, Leu333, Arg288, and Ile326. The local Tyr473 PMF favored a displaced baicalein geometry, with a minimum at 0.66 nm along the Tyr473 hydroxyl-to-ligand-acceptor coordinate. Limited ligand-protonation and His323/His449-tautomer sensitivity screens did not recover persistent canonical AF-2 anchoring under the tested short-screen conditions. Exploratory state analysis resolved in-pocket heterogeneity but did not identify a descriptor-supported state with persistent canonical AF-2 anchoring. These simulations support a constrained structural model in which baicalein samples a pocket-associated, measurably H12-organized, anchor-negative PPARγ ensemble stabilized by non-canonical pocket interactions. The interpretation is limited to simulation descriptors and does not establish receptor activation, partial agonism, phosphorylation regulation, or transcriptional output.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.